Bilingual forms improve cancer treatment understanding among people with limited English
Peer-Reviewed Publication
Updates every hour. Last Updated: 23-Jun-2026 01:16 ET (23-Jun-2026 05:16 GMT/UTC)
People with limited English are significantly more likely to understand the true aim of cancer treatment when given a bilingual consent form, with understanding rising from 35% to 60%, a new study finds.
Sylvester Cancer's March tip sheet contains a variety of cancer-related story ideas including colorectal cancer prevention, exercise during chemotherapy for breast cancer, colorectal and pancreatic cancer immunotherapy research awards, the 2026 Dolphins Cancer Challenge and more.
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found.
Experimental cream that blocks enzyme may offer a precise, better‑tolerated path to prevent and treat cutaneous squamous cell carcinoma
Results from a global phase 3 clinical trial led by investigators at Mass General Brigham show that the medication romiplostim can effectively prevent chemotherapy from destroying platelet-producing bone marrow cells, a common complication known as chemotherapy-induced thrombocytopenia. Romiplostim boosts the bone marrow's ability to withstand the assault of chemotherapy so that recipients of the medication can continue to make platelets that are needed to prevent bleeding.
The team has unexpectedly discovered that cells from the brain defence system play a role in the sexual maturation process. The link between them is RANK, a protein involved in mammary development.
The research has been carried out in animal models, but it has also found genetic mutations associated with a rare syndrome related to infertility in humans.
A protein complex called PRC2 is linked to breast, prostate, blood, and skin cancers. Researchers discovered that removing a specific region within the complex halts cancers in their tracks. This region, called the SBD, could potentially be targeted by cancer inhibitors.
To provide insight into the role structural variants play in pediatric cancer, scientists assembled and curated the first and largest dataset of genomic structural variation specific to childhood cancers. Analysis of the dataset found that the burden of structural variants in pediatric blood cancer is higher than that of their adult counterparts, providing a new understanding of what drives disease formation in these types of cancer.